Author:
Tse Alison,Tseng Hung Fu,Greene Sharon K.,Vellozzi Claudia,Lee Grace M.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference62 articles.
1. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms;Blyth;Vaccine,2011
2. Update Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010–11;MMWR Morb Mortal Wkly Rep,2010
3. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old;Hambidge;JAMA,2006
4. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project;Greene;Am J Epidemiol,2010
5. The safety of trivalent inactivated influenza vaccine in children ages 24 to 59 months;Glanz;Arch Pediatr Adolesc Med,2011